A Study to Learn About How Different Forms of the Study Medicine Called Ritlecitinib Pass the Intestines of Healthy Male Adults When Taken With or Without Food

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 3, 2024

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions

Healthy Volunteers

Interventions

DRUG

Ritlecitinib

Ritlecitinib 100 milligrams (mg) will be provided as either solution or capsule formulation (2 capsules of 50 mg) with 153Sm2O3

Trial Locations (1)

Scintipharma - Lexington - Maywick View Lane, Lexington